217 related articles for article (PubMed ID: 17185803)
1. Acromegaly presenting with diabetic ketoacidosis, associated with retinitis pigmentosa and octreotide-induced bradycardia: a case report and a review of the literature.
Erem C; Ersöz HO; Ukinç K; Avunduk AM; Hacihasanoglu A; Koçak M
Endocrine; 2006 Aug; 30(1):145-9. PubMed ID: 17185803
[TBL] [Abstract][Full Text] [Related]
2. Concurrent diagnosis of acromegaly and diabetic ketoacidosis.
Westphal SA
Endocr Pract; 2000; 6(6):450-2. PubMed ID: 11155217
[TBL] [Abstract][Full Text] [Related]
3. Octreotide LAR for the treatment of acromegaly.
Vallette S; Serri O
Expert Opin Drug Metab Toxicol; 2008 Jun; 4(6):783-93. PubMed ID: 18611118
[TBL] [Abstract][Full Text] [Related]
4. Diabetic ketoacidosis: an unusual presentation of acromegaly.
Dosi RV; Patell RD; Shah PJ; Joshi HK
BMJ Case Rep; 2013 Jun; 2013():. PubMed ID: 23761570
[TBL] [Abstract][Full Text] [Related]
5. First-line octreotide-LAR therapy induces tumour shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial.
Colao A; Pivonello R; Rosato F; Tita P; De Menis E; Barreca A; Ferrara R; Mainini F; Arosio M; Lombardi G
Clin Endocrinol (Oxf); 2006 Mar; 64(3):342-51. PubMed ID: 16487447
[TBL] [Abstract][Full Text] [Related]
6. [Octreotide-induced sinus bradycardia in a male patient with acromegaly].
Lima-Martínez MM; López-Méndez G; Mangupli R
Endocrinol Nutr; 2013 Oct; 60(8):e7-9. PubMed ID: 23415777
[No Abstract] [Full Text] [Related]
7. Inoperable Giant Growth Hormone-secreting Pituitary Adenoma: Radiological Aspects, Clinical Management and Pregnancy Outcome.
Dicuonzo F; Purciariello S; De Marco A; Guastamacchia E; Triggiani V
Endocr Metab Immune Disord Drug Targets; 2019; 19(2):214-220. PubMed ID: 30088454
[TBL] [Abstract][Full Text] [Related]
8. Medical treatment of acromegaly: comorbidities and their reversibility by somatostatin analogs.
Tolis G; Angelopoulos NG; Katounda E; Rombopoulos G; Kaltzidou V; Kaltsas D; Protonotariou A; Lytras A
Neuroendocrinology; 2006; 83(3-4):249-57. PubMed ID: 17047390
[TBL] [Abstract][Full Text] [Related]
9. Heart rate variability is reduced in acromegaly patients and improved by treatment with somatostatin analogues.
Comunello A; Dassie F; Martini C; De Carlo E; Mioni R; Battocchio M; Paoletta A; Fallo F; Vettor R; Maffei P
Pituitary; 2015 Aug; 18(4):525-34. PubMed ID: 25261332
[TBL] [Abstract][Full Text] [Related]
10. [Current alternative in the pharmacotherapy of acromegaly: the long-acting somatostatin analogue octreotide].
Laczi F; Magony S; Julesz J
Orv Hetil; 2002 May; 143(19 Suppl):1062-6. PubMed ID: 12063861
[TBL] [Abstract][Full Text] [Related]
11. A patient with acromegaly who showed remarkable improvement of hyperglycemia after treatment with octreotide.
Hirose T; Kuroda T; Otsuki M; Takagi M; Yamamoto H; Motomura T; Kurebayashi S; Miyashita Y; Koga M; Arita N; Hayakawa T; Kishimoto T; Kasayama S
Intern Med; 1997 May; 36(5):345-50. PubMed ID: 9213172
[TBL] [Abstract][Full Text] [Related]
12. Somatostatin agonists for treatment of acromegaly.
Ben-Shlomo A; Melmed S
Mol Cell Endocrinol; 2008 May; 286(1-2):192-8. PubMed ID: 18191325
[TBL] [Abstract][Full Text] [Related]
13. Acromegaly Presenting With Bilateral Vocal Fold Immobility: Case Report and Review of the Literature.
Cooper T; Dziegielewski PT; Singh P; Seemann R
J Voice; 2016 Nov; 30(6):758.e13-758.e16. PubMed ID: 26452616
[TBL] [Abstract][Full Text] [Related]
14. Mechanism of action of octreotide in acromegalic tumours in vivo using dynamic contrast-enhanced magnetic resonance imaging.
Sathyapalan T; Lowry M; Turnbull LW; Rowland-Hill C; Atkin SL
Pituitary; 2007; 10(3):233-6. PubMed ID: 17541750
[TBL] [Abstract][Full Text] [Related]
15. Pituitary tumor disappearance in a patient with newly diagnosed acromegaly primarily treated with octreotide LAR.
Resmini E; Murialdo G; Giusti M; Boschetti M; Minuto F; Ferone D
J Endocrinol Invest; 2005 Feb; 28(2):166-9. PubMed ID: 15887864
[TBL] [Abstract][Full Text] [Related]
16. Coexistence of ectopic pituitary adenoma and empty sella in a patient with acromegaly : a case report and review of literature.
Hong JF; Ding XH; Wang SS
Neurol India; 2012; 60(3):304-6. PubMed ID: 22824688
[TBL] [Abstract][Full Text] [Related]
17. Rapid progression of amyotrophic lateral sclerosis in an acromegalic patient after surgical resection of a growth hormone-producing pituitary adenoma.
Mondok A; Aranyi Z; Kovacs GG; Czirjak S; Pusztai P; Varga I; Racz K
Neurologist; 2010 Sep; 16(5):315-8. PubMed ID: 20827122
[TBL] [Abstract][Full Text] [Related]
18. Pegvisomant: Balance after 10 years.
Bernabeu I; Marazuela M
Endocrinol Nutr; 2015 Oct; 62(8):363-5. PubMed ID: 26242927
[No Abstract] [Full Text] [Related]
19. Acute liver injury and octreotide.
González-Martín JA; Donnay S; Morillas J; Gómez-Aparicio C; Garcia-Cano J; Pérez-Vigara G; Roldán A
Am J Gastroenterol; 1996 Nov; 91(11):2434-5. PubMed ID: 8931436
[TBL] [Abstract][Full Text] [Related]
20. Pituitary gigantism presenting with depressive mood disorder and diabetic ketoacidosis in an Asian adolescent.
Kuo SF; Chuang WY; Ng S; Chen CH; Chang CN; Chou CH; Weng WC; Yeh CH; Lin JD
J Pediatr Endocrinol Metab; 2013; 26(9-10):945-8. PubMed ID: 23729615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
